European journal of clinical pharmacologyHumansImmune Checkpoint InhibitorsPharmacovigilanceDrug-Related Side Effects and Adverse ReactionsNeoplasms
Safety of immune checkpoint inhibitors: A systematic review of disproportionality analysis studies.
Mahesh Rathod, Maheshwari Kadari, Anjana Das Kadavath, Christy Thomas, Anjali Raveendran, Mahesh Jagtap, Krishna Undela
Published: 202610.1007/s00228-025-03960-1
Abstract
BACKGROUND: Immunotherapy has fundamentally changed the treatment landscape for both solid and hematologic malignancies over the past decade. However, an evolving body of literature has reported immune-related adverse events (irAEs) involving several…
Preview only. Read the full abstract at the source